Home / Amoxicillin and Beta-Lactamase Inhibitor / Sweden
SE ATC J01CR02 · updated 2 Nov 2026
Amoxicillin and Beta-Lactamase Inhibitor shortage in Sweden
Is there an Amoxicillin and Beta-Lactamase Inhibitor shortage in Sweden?
Yes. As of 2 Nov 2026, 3 Amoxicillin and Beta-Lactamase Inhibitor products are reported short in Sweden, the first since 1 Apr 2025. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Also short in Canada, Italy, Spain, Ireland, Switzerland, Czechia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Amoxicillin/Clavulanic acid BB 875 mg/125 mg Blister, 14 tabletter | Brown & Burk IR Limited | 1 Apr 2025 | 31 Dec 2026 | Not stated |
| SE | Amoxicillin/Clavulanic acid BB 500 mg/125 mg Blister, 30 tabletter | Brown & Burk IR Limited | 30 Apr 2026 | 31 Dec 2026 | Not stated |
| SE | Amoxicillin/Clavulanic acid BB 875 mg/125 mg Blister, 20 tabletter | Brown & Burk IR Limited | 30 Apr 2026 | 31 Dec 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.